Logo image of H6D0.DE

HALEON PLC (H6D0.DE) Stock Fundamental Analysis

FRA:H6D0 - Deutsche Boerse Ag - GB00BMX86B70 - Common Stock - Currency: EUR

4.789  +0.07 (+1.57%)

Fundamental Rating

3

Overall H6D0 gets a fundamental rating of 3 out of 10. We evaluated H6D0 against 51 industry peers in the Pharmaceuticals industry. While H6D0 is still in line with the averages on profitability rating, there are concerns on its financial health. H6D0 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year H6D0 was profitable.
H6D0 had a positive operating cash flow in the past year.
Each year in the past 5 years H6D0 has been profitable.
H6D0 had a positive operating cash flow in each of the past 5 years.
H6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFH6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

H6D0 has a Return On Assets (4.20%) which is in line with its industry peers.
H6D0 has a Return On Equity (8.92%) which is in line with its industry peers.
H6D0 has a Return On Invested Capital (6.11%) which is comparable to the rest of the industry.
H6D0 had an Average Return On Invested Capital over the past 3 years of 6.15%. This is significantly below the industry average of 15.13%.
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROIC 6.11%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
H6D0.DE Yearly ROA, ROE, ROICH6D0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

H6D0's Profit Margin of 12.84% is fine compared to the rest of the industry. H6D0 outperforms 62.00% of its industry peers.
In the last couple of years the Profit Margin of H6D0 has grown nicely.
The Operating Margin of H6D0 (21.31%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of H6D0 has grown nicely.
With a Gross Margin value of 60.75%, H6D0 is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
H6D0's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
H6D0.DE Yearly Profit, Operating, Gross MarginsH6D0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so H6D0 is destroying value.
Compared to 1 year ago, H6D0 has less shares outstanding
Compared to 5 years ago, H6D0 has less shares outstanding
The debt/assets ratio for H6D0 is higher compared to a year ago.
H6D0.DE Yearly Shares OutstandingH6D0.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
H6D0.DE Yearly Total Debt VS Total AssetsH6D0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

H6D0 has an Altman-Z score of 1.81. This is a bad value and indicates that H6D0 is not financially healthy and even has some risk of bankruptcy.
H6D0 has a Altman-Z score of 1.81. This is comparable to the rest of the industry: H6D0 outperforms 46.00% of its industry peers.
The Debt to FCF ratio of H6D0 is 5.11, which is a neutral value as it means it would take H6D0, 5.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of H6D0 (5.11) is comparable to the rest of the industry.
H6D0 has a Debt/Equity ratio of 0.53. This is a neutral value indicating H6D0 is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, H6D0 is in line with its industry, outperforming 58.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Altman-Z 1.81
ROIC/WACC0.86
WACC7.1%
H6D0.DE Yearly LT Debt VS Equity VS FCFH6D0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

H6D0 has a Current Ratio of 0.98. This is a bad value and indicates that H6D0 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.98, H6D0 is not doing good in the industry: 78.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.78 indicates that H6D0 may have some problems paying its short term obligations.
The Quick ratio of H6D0 (0.78) is worse than 68.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.78
H6D0.DE Yearly Current Assets VS Current LiabilitesH6D0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.59% over the past year.
Measured over the past years, H6D0 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.56% on average per year.
H6D0 shows a decrease in Revenue. In the last year, the revenue decreased by -0.61%.
The Revenue has been growing slightly by 5.78% on average over the past years.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%32.07%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.25%

3.2 Future

The Earnings Per Share is expected to grow by 13.23% on average over the next years. This is quite good.
Based on estimates for the next years, H6D0 will show a small growth in Revenue. The Revenue will grow by 3.80% on average per year.
EPS Next Y9.06%
EPS Next 2Y8.99%
EPS Next 3Y8.81%
EPS Next 5Y13.23%
Revenue Next Year1.85%
Revenue Next 2Y3.29%
Revenue Next 3Y3.77%
Revenue Next 5Y3.8%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
H6D0.DE Yearly Revenue VS EstimatesH6D0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
H6D0.DE Yearly EPS VS EstimatesH6D0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0.1 0.2 0.3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.80 indicates a rather expensive valuation of H6D0.
The rest of the industry has a similar Price/Earnings ratio as H6D0.
H6D0 is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.21, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 20.79, the valuation of H6D0 can be described as rather expensive.
H6D0's Price/Forward Earnings ratio is in line with the industry average.
H6D0's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.44.
Industry RankSector Rank
PE 22.8
Fwd PE 20.79
H6D0.DE Price Earnings VS Forward Price EarningsH6D0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, H6D0 is valued a bit cheaper than the industry average as 68.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, H6D0 is valued cheaply inside the industry as 86.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.23
EV/EBITDA 9.53
H6D0.DE Per share dataH6D0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates H6D0 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.52
PEG (5Y)1.3
EPS Next 2Y8.99%
EPS Next 3Y8.81%

More info and screens

2

5. Dividend

5.1 Amount

H6D0 has a Yearly Dividend Yield of 1.70%. Purely for dividend investing, there may be better candidates out there.
H6D0's Dividend Yield is comparable with the industry average which is at 3.14.
Compared to the average S&P500 Dividend Yield of 2.42, H6D0 is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.7%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
H6D0.DE Yearly Dividends per shareH6D0.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DPN/A
EPS Next 2Y8.99%
EPS Next 3Y8.81%
H6D0.DE Yearly Income VS Free CF VS DividendH6D0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

HALEON PLC

FRA:H6D0 (5/9/2025, 7:00:00 PM)

4.789

+0.07 (+1.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-30 2025-04-30
Earnings (Next)N/A N/A
Inst Owners49.58%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap21.59B
Analysts77.6
Price Target5 (4.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.7%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.54%
PT rev (3m)-0.44%
EPS NQ rev (1m)-0.29%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.42%
EPS NY rev (3m)-1.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-1.19%
Valuation
Industry RankSector Rank
PE 22.8
Fwd PE 20.79
P/S 1.63
P/FCF 9.23
P/OCF 7.95
P/B 1.13
P/tB N/A
EV/EBITDA 9.53
EPS(TTM)0.21
EY4.39%
EPS(NY)0.23
Fwd EY4.81%
FCF(TTM)0.52
FCFY10.83%
OCF(TTM)0.6
OCFY12.57%
SpS2.94
BVpS4.23
TBVpS-2.63
PEG (NY)2.52
PEG (5Y)1.3
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROCE 8.4%
ROIC 6.11%
ROICexc 6.63%
ROICexgc 4145.85%
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
FCFM 17.65%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Debt/EBITDA 3.18
Cap/Depr 98.15%
Cap/Sales 2.83%
Interest Coverage 6.65
Cash Conversion 84.66%
Profit Quality 137.52%
Current Ratio 0.98
Quick Ratio 0.78
Altman-Z 1.81
F-Score6
WACC7.1%
ROIC/WACC0.86
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%32.07%
EPS Next Y9.06%
EPS Next 2Y8.99%
EPS Next 3Y8.81%
EPS Next 5Y13.23%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.25%
Revenue Next Year1.85%
Revenue Next 2Y3.29%
Revenue Next 3Y3.77%
Revenue Next 5Y3.8%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year15.06%
EBIT Next 3Y9.08%
EBIT Next 5Y10.44%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%